This article is brought to you in association with the European Commission. The European Commission has approved, under the EU Merger Regulation, the acquisition of Pfizer’s Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer’s topical pain management business carried out under the ThermaCare brand. GlaxoSmithKline (“GSK”) and Pfizer’s Consumer Health Business […]Mergers: Commission approves GlaxoSmithKline’s acquisition of Pfizer’s Consumer Health Business, subject to conditions
July 11, 2019 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission has approved, under the EU Merger Regulation, the acquisition of Pfizer’s Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer’s topical pain management business carried out under the ThermaCare brand. GlaxoSmithKline (“GSK”) and Pfizer’s Consumer Health Business […]Pharmaceuticals conceal drug side effects with the EU’s Court blessing
May 8, 2013 by 1 Comment
When was the last time you heard about a famous drug that had to be withdrawn from the market after it had cost hundreds or thousands of lives to the patients who had been prescribed with? Did you think it was due to an accident or human error during production? How would you feel if you found […]
